SCHEMBL657606

SCHEMBL657606

Nc1cc2ccsc2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.50
PDPK1 O15530 1/20 0.47
CYP2A6 P11509 2/20 0.41
PIK3CB P42338 1/20 0.39
KDM1A O60341 1/20 0.37
KDM4E B2RXH2 2/20 0.37
GRM4 Q14833 1/20 0.37
NOS1 P29475 3/20 0.35
NOS3 P29474 2/20 0.35
NOS2 P35228 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
PPARG P37231 1/20 0.35
HTT P42858 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659466 0.75 GRM4 (0.40) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL660629 0.75 DYRK1A (0.38) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL157982 0.75 CYP2A6 (0.47) DYRK1ACYP2A6PIK3CBKDM1AKDM4E
SCHEMBL8114596 0.75 DYRK1A (0.38) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL659606 0.75 DYRK1A (0.38) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL1207766 0.72 CHRNA7 (0.48) DYRK1ACYP2A6GRM4LMNACHRNA7
Hydrochloric Acid SCHEMBL27687894 0.71 CHRNA7 (0.47) DYRK1ACYP2A6GRM4LMNACHRNA7
SCHEMBL18237423 0.71 KDM1A (0.39) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL21666073 0.71 KDM4E (0.38) DYRK1ACYP2A6KDM1AKDM4EGRM4
SCHEMBL20631749 0.71 KDM4E (0.41) DYRK1ACYP2A6PIK3CBKDM4EGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 DYRK1A 2154/4885PDPK1 510/4885CYP2A6 1912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.